/PRNewswire/ CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted.
SEATTLE, May 1, 2023 /PRNewswire/ CTI BioPharma Corp. , a commercial biopharmaceutical company focused on the development and commercialization of novel targeted therapies for blood-related. | May 1, 2023
ALPHARETTA, Ga., April 27, 2023 Clearside Biomedical, Inc. , a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space ,. | April 27, 2023
- Multiple U.S. Clinical Sites to Begin Enrolling ODYSSEY Participants This Quarter - - ODYSSEY Topline Results Expected in Q3 2024 - ALPHARETTA, Ga.,.
/PRNewswire/ CTI BioPharma Corp. (Nasdaq: CTIC), a commercial biopharmaceutical company focused on the development and commercialization of novel targeted.